Arbutus Biopharma Corporation (ABUS) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -8.11M | -4.68M | -5.82M | -15.75M | -13.39M | -10.31M | -20.74M | -14.5M | -19.3M | -17.29M | -21.78M | -19.56M | -27.3M | -16.99M | -18.69M | -20.29M | 20.62M | -19.61M | -16.04M | -14.01M |
| Operating CF Margin % | -4.53% | -445.29% | -1099.62% | -146.65% | -759.13% | -655.34% | -1548.62% | -840.32% | -1259.46% | -806.15% | -467.67% | -420.53% | -408.27% | -272.06% | -314.05% | -142.5% | 163.89% | -611.54% | -480.12% | -601.5% |
| Operating CF Growth % | 39.44% | 54.63% | 71.95% | -8.58% | 30.6% | 40.35% | 4.81% | 25.84% | 29.32% | -1.78% | -16.54% | 3.62% | -232.41% | 13.34% | -16.56% | -44.86% | 215.31% | -30.59% | -31.72% | -59.18% |
| Net Income | 169.69M | -3.76M | -7.74M | 2.52M | -24.53M | -12.53M | -19.72M | -19.8M | -17.88M | -19.31M | -20.1M | -17.09M | -16.34M | -21.93M | -17.57M | -14.19M | -15.77M | -21.32M | -19.16M | -19.39M |
| Depreciation & Amortization | 11K | 1.03M | 11K | 11K | 330K | 333K | 336K | 356K | 355K | 359K | 369K | 342K | 334K | 307K | 343K | 383K | 394K | 427K | 447K | 436K |
| Stock-Based Compensation | 1.36M | 14.95M | 1.26M | 864K | 3.56M | 1.63M | 2.16M | 3.18M | 2.01M | 1.72M | 2.48M | 2.96M | 2.13M | 1.67M | 1.72M | 2.06M | 1.74M | 1.43M | 1.61M | 1.74M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 241K | 0 | 0 |
| Other Non-Cash Items | -309K | -18.86M | -499K | -907K | 1.97M | 481K | -1.02M | -1M | -930K | -1.55M | -1.15M | -1.77M | -1.09M | -546K | -1.78M | -935K | -488K | -1.39M | 13K | 604K |
| Working Capital Changes | -178.87M | 1.96M | 1.15M | -18.24M | 5.27M | -229K | -2.5M | 2.76M | -2.86M | 1.49M | -3.38M | -4M | -12.33M | 3.51M | -1.4M | -7.61M | 34.74M | 1.01M | 1.05M | 2.6M |
| Change in Receivables | -177.58M | -149.21K | 120K | 157K | 1.23M | -801K | 159K | 372K | -363K | 395K | 443K | 50K | -1.31M | 483K | 135K | -657K | -414K | 768K | -369K | -33K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.91M | 0 | 0 |
| Change in Payables | -985K | 846.28K | 0 | 0 | 4.54M | 0 | 0 | 0 | -2.02M | 0 | 0 | -848K | -6.38M | 0 | -204K | 3.76M | -2.1M | 1.91M | 1.17M | 2.21M |
| Cash from Investing | 2.2M | -1.36M | -10.02M | 15.61M | 11.35M | 13.41M | -11.99M | 9.83M | 11.69M | 22.23M | 10.43M | 1.44M | 16.68M | 12.68M | -13.74M | -13.83M | -60.06M | -8.12M | 15.97M | -38.75M |
| Capital Expenditures | 0 | 0 | 0 | 9K | 0 | -86K | 0 | -1K | -95K | 0 | -32K | -859K | -117K | -134K | -91K | -212K | -75K | -58K | -20K | -632K |
| CapEx % of Revenue | - | 0% | - | 0.08% | - | 5.46% | - | 0.06% | 6.2% | - | 0.69% | 18.47% | 1.75% | 2.15% | 1.53% | 1.49% | 0.6% | 1.81% | 0.6% | 27.14% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 37.19M | 0 | 0 | 0 | 37M | 0 | 0 | 0 | 0 | 1.81M | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 353K | 157.18M | 0 | 0 | 0 | 0 | 0 | 0 | -37.19M | 0 | 20K | 0 | -37M | -20K | 0 | 20K | 0 | -1.81M | 0 | 0 |
| Cash from Financing | 11.62M | 1.64M | 844K | 453K | 2.78M | 1.42M | 1.77M | 24.37M | 24.43M | 3.81M | 1.68M | 4.74M | 20.42M | 11.08M | 9.13M | 113K | 11.48M | 59.12M | 46.95M | 4.29M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 11.62M | 1.59M | 0 | 0 | 0 | -1K | 0 | 22.36M | 21.77M | 3.85M | 1.4M | 4.74M | 19.86M | 11.08M | 8.97M | 0 | 268K | 59.24M | 44.74M | 4.27M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -12.14M | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 50.65K | 844K | 453K | 2.78M | 1.42M | 1.77M | 2.01M | 2.67M | -45K | 285K | 0 | 555K | 1K | 159K | 113K | 11.22M | 12.02M | 2.22M | 15K |
| Net Change in Cash | 5.7M | -4.4M | -15M | 336K | 746K | 4.48M | -30.94M | 19.69M | 16.82M | 8.75M | -9.67M | -13.38M | 9.8M | 6.77M | -23.32M | -34.01M | -27.95M | 31.4M | 46.93M | -48.47M |
| Free Cash Flow | -8.11M | -4.68M | -5.82M | -15.75M | -13.39M | -10.4M | -20.74M | -14.51M | -19.39M | -17.29M | -21.82M | -20.42M | -27.42M | -17.12M | -18.78M | -20.5M | 20.54M | -19.66M | -16.06M | -14.64M |
| FCF Margin % | -4.53% | -445.29% | -1099.62% | -146.65% | -759.13% | -660.8% | -1548.62% | -840.38% | -1265.67% | -806.15% | -468.36% | -439% | -410.02% | -274.2% | -315.57% | -143.99% | 163.29% | -613.35% | -480.72% | -628.64% |
| FCF Growth % | 39.44% | 55% | 71.95% | -8.58% | 30.94% | 39.85% | 4.95% | 28.96% | 29.28% | -0.98% | -16.15% | 0.42% | -233.46% | 12.92% | -16.98% | -40.05% | 214.26% | -29.67% | -31.77% | -65.12% |
| FCF per Share | -0.04 | -0.02 | -0.03 | -0.08 | -0.07 | -0.05 | -0.11 | -0.08 | -0.11 | -0.10 | -0.13 | -0.12 | -0.17 | -0.11 | -0.12 | -0.14 | 0.14 | -0.19 | -0.16 | -0.15 |
| FCF Conversion (FCF/Net Income) | -0.05x | 1.25x | 0.75x | -6.24x | 0.55x | 0.82x | 1.05x | 0.73x | 1.08x | 0.90x | 1.08x | 1.14x | 1.67x | 0.77x | 1.06x | 1.43x | -1.31x | 0.92x | 0.84x | 0.72x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |